Key Metrics
10.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
97
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.86
5-Year SI
5-year SI
- N/A 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Endocrinology
SJR
- Q1 Endocrinology
- Q1 Medicine (miscellaneous)
- Q1 Medical Laboratory Technology
- Q1 Endocrinology, Diabetes and Metabolism
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.97
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Quality of life
- Hypoglycemia
- Continuous glucose monitoring
- Type 2 diabetes
- Clinical trial
- Exercise
- Randomized controlled trial
- Health care
- Artificial intelligence
- Insulin pump
- Standard deviation
- Type 2 Diabetes Mellitus
- Nonalcoholic fatty liver disease
- Insulin delivery
- Intensive care unit
- Diabetic ketoacidosis
- Diabetes management
- Insulin dose
- Interquartile range
- Feasibility study
Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Diabetes Technology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Automated Insulin Delivery Effects During Driving Among Older Adults with Type 1 Diabetes in a Randomized Trial.
- 2 Dec 24
- Diabetes technology & therapeutics
-
Full paper
Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care.
- 2 Dec 24
- Diabetes technology & therapeutics
-
Full paper
A Telehealth Program Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap in Nursing Homes for Older Adults with Insulin-Treated Diabetes: The Trescasas Study.
- 26 Nov 24
- Diabetes technology & therapeutics
-
Full paper
Comment on Preechasuk et al: Switching from Intermittently-Scanned Continuous Glucose Monitoring to Real-Time Continuous Glucose Monitoring with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia.
- 26 Nov 24
- Diabetes technology & therapeutics
-
Full paper
The Impact of Public Policy on Equitable Access to Technology for Children and Youth Living with Type 1 Diabetes in British Columbia, Canada.
- 26 Nov 24
- Diabetes technology & therapeutics
-
Full paper
Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control.
- 26 Nov 24
- Diabetes technology & therapeutics
Scite analysis
Powered by scite_
3.5k articles received 75.6k citations see all
- 2,750 Supporting
- 70,176 Mentioning
- 516 Contrasting
Editorial notices
- 5 Retractions
- 1 Withdrawals
- 0 Corrections
- 13 Errata
- 0 Expression of Concern
FAQs
How long has Diabetes Technology and Therapeutics been actively publishing?
Diabetes Technology and Therapeutics has been in operation since 1999 till date.
What is the publishing frequency of Diabetes Technology and Therapeutics ?
Diabetes Technology and Therapeutics published with a Monthly frequency.
How many articles did Diabetes Technology and Therapeutics publish last years ?
In 2023, Diabetes Technology and Therapeutics published 140 articles.
What is the eISSN & pISSN for Diabetes Technology and Therapeutics ?
For Diabetes Technology and Therapeutics,eISSN is 1557-8593 and pISSN is1520-9156.
What is Citescore for Diabetes Technology and Therapeutics ?
Citescore for Diabetes Technology and Therapeutics is 10.3.
What is H index for Diabetes Technology and Therapeutics ?
H index for Diabetes Technology and Therapeutics is 97.
What is SNIP score for Diabetes Technology and Therapeutics ?
SNIP score for Diabetes Technology and Therapeutics is 1.97.
What is the SJR for Diabetes Technology and Therapeutics ?
SJR for Diabetes Technology and Therapeutics is Q1.
Who is the publisher of Diabetes Technology and Therapeutics ?
MARY ANN LIEBERT, INC is the publisher of Diabetes Technology and Therapeutics.